Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vor Biopharma Inc (NQ: VOR ) 0.9700 +0.0100 (+1.04%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 29, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Vor Biopharma Inc < Previous 1 2 3 4 5 Next > Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday's Mid-Day Session December 07, 2022 Gainers Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session December 07, 2022 Via Benzinga Nasdaq Drops 75 Points; Crude Oil Down 2% December 07, 2022 U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping 75 points on Wednesday. Via Benzinga Expert Ratings for Vor Biopharma May 13, 2022 Analysts have provided the following ratings for Vor Biopharma (NASDAQ:VOR) within the last quarter: Via Benzinga Stocks That Hit 52-Week Lows On Wednesday May 11, 2022 On Wednesday, 807 companies reached new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Friday March 25, 2022 On Friday, 166 companies set new 52-week lows. Points of Interest From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session December 07, 2022 Via Benzinga Vor Bio Prices Underwritten Offering of Common Stock and Concurrent Private Placement for Aggregate Proceeds of $115.8 Million December 07, 2022 From Vor Biopharma Via GlobeNewswire First AML Patient Successfully Transplanted with Vor Bio’s Investigational Trem-cel (VOR33) and Tolerated Mylotarg™ December 07, 2022 From Vor Biopharma Via GlobeNewswire Vor Bio to Participate in Upcoming Investor Conferences November 22, 2022 From Vor Biopharma Via GlobeNewswire Vor Bio Reports Third Quarter 2022 Financial Results and Provides Company Update November 10, 2022 From Vor Biopharma Via GlobeNewswire Vor Bio to Participate in Upcoming Investor Conferences November 01, 2022 From Vor Biopharma Via GlobeNewswire Vor Bio Appoints Eyal C. Attar, M.D. as Chief Medical Officer October 12, 2022 From Vor Biopharma Via GlobeNewswire Vor Bio Demonstrates Potential of Base and Sequential Multiplex Editing of Hematopoietic Stem Cells for Next-generation AML Treatment October 11, 2022 From Vor Biopharma Via GlobeNewswire Vor Bio Initiates In-house Clinical Manufacturing at Cambridge, MA Headquarters September 28, 2022 Facility to support clinical manufacturing for Vor Bio’s novel cell and genome engineering pipeline while reducing the time and cost required to manufacture its eHSC and CAR-T product candidates From Vor Biopharma Via GlobeNewswire Why Virios Therapeutics Is Trading Lower By 75%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session September 20, 2022 Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 51% to $0.4957. Crown ElectroKinetics, last month, posted a Q4 net loss of $4.5 million. Via Benzinga 3 Biotech Stock Picks From This Wedbush Analyst July 27, 2022 While the S&P 500 index peaked in January and has had a rough year, the biotech sector peaked last August. For the time being, both have found a short-term and possible long-term bottom in June. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2022 July 26, 2022 Upgrades Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session July 25, 2022 Gainers Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session July 06, 2022 Gainers Via Benzinga 76 Biggest Movers From Yesterday: Ocean Bio-Chem, Athira Pharma And More June 23, 2022 Gainers Ocean Bio-Chem, Inc. (NASDAQ: OBCI) shares climbed 117.2% to close at $12.86 on Wednesday after the company announced it will be acquired by OneWater Marine for $13.08 per share in cash. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session June 22, 2022 Via Benzinga 79 Biggest Movers From Yesterday June 08, 2022 Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 154.7% to settle at $12.10 on Tuesday on continued strength after the FDA granted clearance for the company's pūrgo technology, classifying it... Via Benzinga Stocks That Hit 52-Week Lows On Monday May 16, 2022 On Monday, 198 companies reached new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Friday May 13, 2022 On Friday, 153 companies set new 52-week lows. Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session April 07, 2022 Gainers Trevi Therapeutics (NASDAQ:TRVI) stock rose 45.8% to $2.77 during Thursday's regular session. Trevi Therapeutics's stock is trading at a volume of 15.2... Via Benzinga Akron BioProducts and Vor Bio to Collaborate on the Development and cGMP Manufacture of Nucleases March 22, 2022 From Akron BioProducts Via Business Wire Stocks That Hit 52-Week Lows On Monday March 28, 2022 On Monday, 147 stocks hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For December 17, 2021 December 17, 2021 Upgrades According to Morgan Stanley, the prior rating for Definitive Healthcare Corp (NASDAQ: Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For December 3, 2021 December 03, 2021 Upgrades Cowen & Co. upgraded the previous rating for Marvell Technology Inc (NASDAQ: Via Benzinga < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.